| 发明名称 |
Use of Soluble Fgl2 As An Immunosuppressant |
| 摘要 |
Methods and compositions for inducing immune suppression are disclosed. The methods involve administering an effective amount of a soluble fgl2 protein or a nucleic acid encoding a soluble fgl2 protein. The methods are useful in preventing graft rejection, autoimmune disease, and allergies.
|
| 申请公布号 |
US2010048486(A1) |
申请公布日期 |
2010.02.25 |
| 申请号 |
US20090611496 |
申请日期 |
2009.11.03 |
| 申请人 |
VERITAS THERAPEUTICS INC. |
发明人 |
LEVY GARY |
| 分类号 |
C07K14/475;A61K38/18;A61K38/36;A61K38/48;A61P37/06;C12N9/64;C12N15/12;G01N33/566 |
主分类号 |
C07K14/475 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
